April 21, 2008, Holliston, MA — Digilab Genomic Solutions® (DGS) today announced it has entered into Distribution and Supply and License and Supply Agreements with CyBio AG. Under these agreements, DGS and CyBio will collaborate on manufacture and distribution of the DGS Hummingbird-Plus instrument. Digilab will supply Hummingbird® dispensing heads and cassettes (both in 96 and 384-well format) to CyBio and CyBio will manufacture the DGS Hummingbird-Plus instrument, integrating DGS Hummingbird heads/cassettes with its modular CyBi®-Well automation platform. Digilab will distribute the Hummingbird-Plus instruments worldwide. The Hummingbird-Plus is a universal parallel pipetting instrument for ultra low volume range applications (down to 25nL). The capillary-based pipetting technology of Digilab’s HummingBird product line is now completely integrated into the modular CyBi®-Well automation platform. Whenever DMSO-related issues (e.g. compound precipitations or assay interferences) arise, the Hummingbird-Plus provides the required solution. Due to its very low transfer volumes, compounds can be added directly to an assay plate without the need to prepare intermediate plates. In addition to collaboration on the DGS Hummingbird-Plus, Digilab will license intellectual property related to dispensing heads for use in connection with CyBio’s CyBi®-Well vario instrument. Additionally, Digilab will manufacture and supply the capillary cassettes for the CyBi®-Well vario instrument. “These two agreements broaden the existing business partnership between Digilab and CyBio. The expanded collaboration takes full advantage of the complimentary expertise of our two companies, resulting in more flexible tools and workflow solutions for principally the drug discovery and high-throughput screening markets” commented Jennifer Wu, DGS’s global product manager for genomics and liquid handling systems. “With the agreement we can address a broader range of customers now. Due to the continuous advancement of our mulitchannel pipettor CyBi®-Well vario we strengthen our worldwide leading position in the field of parallel pipetting. The combination of a sophisticated capillary technology with carefully designed instrument details allows faster automation of compound transfer directly from stock.” said Hanno Hermann, product manager multichannel at CyBio AG. About Digilab Genomic Solutions Digilab Genomic Solutions (formerly Genomic Solutions, Inc) provides innovative robotic and automation equipment for the global life science and biotechnology research community. Digilab Genomic Solutions develops and manufactures instrumentation, software, and consumables serving genomics, proteomics and high-throughput drug discovery. Our products enable researchers to perform complex, high volume experiments at a lower cost and in less time than traditional techniques. Digilab; a global leader in molecular spectroscopy systems for over 40 years focusing on sample preparation, bioinformatics, and detection/analysis tools enabling solutions for the life sciences research and in-vitro diagnostics markets, including pharmaceutical and biotech industries, as well universities and governments. Digilab works with companies such as AstraZeneca, Boehringer Ingelheim, Merck & Co, Novartis, Novo Nordisk, Roche Diagnostics, Abbott Diagnostics, and Solvay Pharmaceuticals to address their needs for novel peptide biomarkers, diagnostics, and bioactive peptides for targeted therapeutics. Digilab acquired SpectraCode in West Lafayette Indiana, a technology leader in Raman Spectroscopy and developer of systems/solutions for portable “point of need” molecular spectroscopy identification. Digilab concluded an exclusive OEM Distribution Agreement with Boehringer Ingelheim Microparts under which it commercializes Boehringer Ingelheim proprietary MicroSystems Technology (MST) Microspectrometers. Digilab and Boehringer Ingelheim also have a cooperation to bring point of need molecular spectroscopy devices to the marketplace. Digilab acquired BioVisioN GmbH, now Digilab Peptidomics®, has developed and commercializes internationally patented Peptidomics products and services. Digilab MAIA Scientific develops instrumentation and software for high information content screening: the MIAS-2 microscopic readers and the eaZYX software. DMS’ innovative products combine unequaled flexibility, sensitivity and speed for automated analysis of cells, tissues, beads and/or model organisms. The addition of Digilab Genomic Solutions and MAIA Scientific to Digilab, Inc, has completed Digilab as the “Family of Life Science Solutions”. Portrait of CyBio AG As a global market leader in the field of simultaneous pipetting technology, CyBio’s products set standards in terms of precision, reliability and simplicity. Over and above its core segment, CyBio has successfully extended its offerings to the market segments of system integration and contract development. CyBio has its roots in high-quality engineering and with almost 20 years of experience in laboratory automation technologies. More than 150 highly specialized and committed employees guarantee CyBio’s high quality claims in every aspect of the business. A dedicated sales force and a global network of distributors strengthen CyBio’s position as a leading company in the field of liquid handling. CyBio’s clients are leading pharmaceutical and biotechnology companies, as well as academic research institutes.